World Muscle Society Congress 2022 (WMS)

Back

Building A FORCE™ Platform-Based DMD Franchise for the Treatment of Individuals With Mutations Amenable to Exon Skipping (poster)

View

©2026 Dyne Therapeutics, Inc. All rights reserved MED-00978. Date of preparation: July 2026.